SBIR/STTR Research Award
Intraoperative Analytics and Enhanced Patient Outcomes
Award amount
$255,719Program and phase
STTR · Phase IAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- M&S Biotics, Inc.
- Proposal award date
- 2020-04-05
- Contract end date
- 2021-04-04
- UEI
- XJ57KSGKPYK5
- Solicitation number
- PA19-270
- Topic code
- NCATS
Research abstract
PROJECT SUMMARY / ABSTRACT
Prolonged operative times are associated with significant patient morbidity and mortality, and multiple studies
have quantified the degree to which prolonged operative time increases a patientandapos;s risk of adverse complications,
like infections. Similarly, ineffective asset management in the OR leads to inefficient utilization of resources and
may contribute to prolonged operative times. Multiple studies have noted that if surgical teams were more familiar
with the procedural equipment and its location thereof, such pre-operative planning could reduce the amount of
time spent making critical decisions during operation and allow the anticipation of any additional equipment
needed. Unfortunately, there is currently no way to collect the data to quantify pre-operative planning optimization,
equipment usage, nor any of the countless metrics that define best practices in the operating room. If the
capability to track the location and usage of instrumentation existed, hospitals would be able to optimize
their surgical sets based on usage, have quantified metrics behind surgeon preference, and correlate
certain techniques with positive patient outcomes.
Mandamp;S Biotics proprietary RFID scanning technology presents the possibility to passively collect data points related
to instrument usage and offer insights into a variety of potential informatics such as surgical set optimization,
patient outcomes, instrument longevity, technique variation, operating room throughput, and patient safety. The
proposed research in Phase I will focus on (Aim 1) conducing a formative usability study of Mandamp;S Bioticsandapos; “Biotic
System” with surgical experts at The Baylor College of Medicine and (Aim 2) collecting intraoperative data in a
pre-clinical setting to inform a larger clinical study. The design of a comprehensive clinical trial using the Biotic
System as a means of reducing operative time and quantifying surgical insights would be the next stage following
this STTR project.PROJECT NARRATIVE
The proposal aims to test and improve a novel system to passively collect and quantify intraoperative data points
related to surgical instrument usage. In doing so it, it will offer insights into a variety of potential informatics such
as surgical set optimization, patient outcomes, instrument longevity, technique variation, operating room
throughput, and patient safety. State of the art technology that complies with the FDAandapos;s Unique Device
Identification (UDI) mandate drastically interrupts work-flow and does not perform any intraoperative analytics.
The small business partner has developed a surgical instrument tracking and information gathering system that
fits seamlessly into any operating room. The academic partner has countless experts in a variety of surgical
fields, with a significant track record of success. Together, we are aiming to test and improve the Biotic System
as a means of data collection and analytics in order to improve the efficiency of surgical cases for the benefit of
both the surgical teams and patients involved.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A Novel Multi-Lineage Human Intestinal Organoid Screening Platform for Drug Discovery and Preclinical Testing
- A Novel Approach to Eliminate Length Impurities for High-Quality mRNA Production
- Development of CIL-0X: A Platform to Enhance Delivery of Inhaled RNA Therapeutics to Lung Cells
- Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells
- Long-read sequencing-based diagnosis for complex genomic and DNA methylation changes